Sundar.M
☆    

India,
2019-02-15 14:37
(2329 d 12:36 ago)

Posting: # 19925
Views: 2,530
 

 Dose curve [PK / PD]

Post reply
Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
 
UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,682 registered users;
41 visitors (0 registered, 41 guests [including 14 identified bots]).
Forum time: 04:14 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5